GLP-1-based therapies: the dilemma of uncertainty. [electronic resource]
Producer: 20110907Description: 20-3 p. digitalISSN:- 1528-0012
- Diabetes Mellitus, Type 2 -- drug therapy
- Dipeptidyl-Peptidase IV Inhibitors -- adverse effects
- Exenatide
- Glucagon-Like Peptide-1 Receptor
- Humans
- Hypoglycemic Agents -- adverse effects
- Pancreatic Neoplasms -- chemically induced
- Pancreatitis -- chemically induced
- Peptides -- adverse effects
- Pyrazines -- adverse effects
- Receptors, Glucagon -- agonists
- Risk Assessment
- Risk Factors
- Sitagliptin Phosphate
- Thyroid Neoplasms -- chemically induced
- Triazoles -- adverse effects
- Uncertainty
- Venoms -- adverse effects
No physical items for this record
Publication Type: Editorial; Comment
There are no comments on this title.
Log in to your account to post a comment.